Impulse control disorders and depression in Finnish patients with Parkinson's disease

Parkinsonism and Related Disorders

Volumn 18, Issue 2, 2012, Pages 155-160

  Joutsa, Juho ^a,b   Martikainen, Kirsti ^c   Vahlberg, Tero ^b   Voon, Valerie ^d   Kaasinen, Valtteri ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c The Finnish Parkinson Association   (Finland)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

BDI; Depression; Parkinson's disease; QUIP; SOGS

Indexed keywords

BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR; PRAMIPEXOLE; ROPINIROLE;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BECK DEPRESSION INVENTORY; CROSS-SECTIONAL STUDY; DEPRESSION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ETHNIC GROUP; FEMALE; FINNISH; GENDER; HUMAN; IMPULSE CONTROL DISORDER; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; QUESTIONNAIRE; QUESTIONNAIRE FOR IMPULSIVE COMPULSIVE DISORDERS IN PARKINSON DISEASE; SOUTH OAKS GAMBLING SCREEN;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; FINLAND; GAMBLING; HUMANS; IMPULSE CONTROL DISORDERS; MALE; MIDDLE AGED; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; REGISTRIES; RISK FACTORS;

EID: 84856233667     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.09.007     Document Type: Article

References (30)

1. Weintraub D., Koester J., Potenza M., Siderowf A., Stacy M., Voon V., et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010 May, 67(5):589-595.
2. Ambermoon P., Carter A., Hall W.D., Dissanayaka N.N., O'Sullivan J.D. Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field. Addiction 2011 Feb, 106(2):283-293.
3. Lorains F.K., Cowlishaw S., Thomas S.A. Prevalence of comorbid disorders in problem and pathological gambling: systematic review and meta-analysis of population surveys. Addiction 2011 Jan.
4. Coleman E., Raymond N., McBean A. Assessment and treatment of compulsive sexual behavior. Minn Med 2003 Jul, 86(7):42-47.
5. Lejoyeux M., Weinstein A. Compulsive buying. Am J Drug Alcohol Abuse 2010 Sep, 36(5):248-253.
6. Araujo D.M., Santos G.F., Nardi A.E. Binge eating disorder and depression: a systematic review. World J Biol Psychiatry 2010 Mar, 11(2 Pt 2):199-207.
7. Voon V., Sohr M., Lang A.E., Potenza M.N., Siderowf A.D., Whetteckey J., et al. Impulse control disorders in parkinson disease: a multicenter case-control study. Ann Neurol 2011 Jun, 69(6):986-996.
8. Aarsland D., Marsh L., Schrag A. Neuropsychiatric symptoms in Parkinson's disease. Mov Disord 2009 Nov, 24(15):2175-2186.
9. Avanzi M., Baratti M., Cabrini S., Uber E., Brighetti G., Bonfà F. Prevalence of pathological gambling in patients with Parkinson's disease. Mov Disord 2006 Dec, 21(12):2068-2072.
10. Isaias I.U., Siri C., Cilia R., De Gaspari D., Pezzoli G., Antonini A. The relationship between impulsivity and impulse control disorders in Parkinson's disease. Mov Disord 2008 Feb, 23(3):411-415.
11. Grosset K.A., Macphee G., Pal G., Stewart D., Watt A., Davie J., et al. Problematic gambling on dopamine agonists: not such a rarity. Mov Disord 2006 Dec, 21(12):2206-2208.
12. Strickland D., Bertoni J.M. Parkinson's prevalence estimated by a state registry. Mov Disord 2004 Mar, 19(3):318-323.
13. Weintraub D., Hoops S., Shea J., Lyons K., Pahwa R., Driver-Dunckley E., et al. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord 2009 Jul, 24(10):1461-1467.
14. Lesieur H., Blume S. The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 1987 Sep, 144(9):1184-1188.
15. Beck A., Steer R., Garbin M. Psychometric properties of the Beck depression inventory - 25 years of evaluation. Clin Psychol Rev 1988, 77-100.
16. Schrag A., Barone P., Brown R.G., Leentjens A.F., McDonald W.M., Starkstein S., et al. Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2007 Jun, 22(8):1077-1092.
17. Tomlinson C.L., Stowe R., Patel S., Rick C., Gray R., Clarke C.E. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010 Nov, 25(15):2649-2653.
18. Aho P., Turja T. Gambling in Finland (in Finnish). Ministry Soc Aff Health 2007.
19. Volberg R.A. The prevalence and demographics of pathological gamblers: implications for public health. Am J Public Health 1994 Feb, 84(2):237-241.
20. Ladouceur R., Jacques C., Chevalier S., Sévigny S., Hamel D. Prevalence of pathological gambling in Quebec in 2002. Can J Psychiatry 2005 Jul, 50(8):451-456.
21. Voon V., Hassan K., Zurowski M., Duff-Canning S., de Souza M., Fox S., et al. Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology 2006 Jun, 66(11):1750-1752.
22. Fan W., Ding H., Ma J., Chan P. Impulse control disorders in Parkinson's disease in a Chinese population. Neurosci Lett 2009 Nov, 465(1):6-9.
23. Lee J.Y., Kim J.M., Kim J.W., Cho J., Lee W.Y., Kim H.J., et al. Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. Parkinsonism Relat Disord 2010 Mar, 16(3):202-207.
24. Gallagher D.A., O'Sullivan S.S., Evans A.H., Lees A.J., Schrag A. Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord 2007 Sep, 22(12):1757-1763.
25. Bostwick J.M., Hecksel K.A., Stevens S.R., Bower J.H., Ahlskog J.E. Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease. Mayo Clin Proc 2009 Apr, 84(4):310-316.
26. Ondo W.G., Lai D. Predictors of impulsivity and reward seeking behavior with dopamine agonists. Parkinsonism Relat Disord 2008, 14(1):28-32.
27. Singh A., Kandimala G., Dewey R.B., O'Suilleabhain P. Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists. JClin Neurosci 2007 Dec, 14(12):1178-1181.
28. Antonini A., Siri C., Santangelo G., Cilia R., Poletti M., Canesi M., et al. Impulsivity and compulsivity in drug-naïve patients with Parkinson's disease. Mov Disord 2011 Feb, 26(3):464-468.
29. Reijnders J.S., Ehrt U., Weber W.E., Aarsland D., Leentjens A.F. Asystematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 2008 Jan, 23(2):183-189. quiz 313.
30. Potenza M.N., Xian H., Shah K., Scherrer J.F., Eisen S.A. Shared genetic contributions to pathological gambling and major depression in men. Arch Gen Psychiatry 2005 Sep, 62(9):1015-1021.